Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?

The number of available biological therapies have doubled over the last 10 years and the arrival of novel molecules (interleukin 23p19 inhibitors) is ongoing alongside the development of small molecules. As a result of this vast landscape of treatment, positioning advanced therapies (according to cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Juillerat, Pascal, Grueber, Maude Martinho, Ruetsch, Roseline, Santi, Giulia, Vuillèmoz, Marianne, Michetti, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Medical Management of IBD Edited by Joana Torres and Ryan Ungaro
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092374/
https://www.ncbi.nlm.nih.gov/pubmed/35570855
http://dx.doi.org/10.1016/j.crphar.2022.100104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092374/
https://www.ncbi.nlm.nih.gov/pubmed/35570855
http://dx.doi.org/10.1016/j.crphar.2022.100104

Ejemplares similares